Information Minister Zahir Uddin Swapon emphasizes the importance of data in public relations at a training program for PROs, ...

TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts and reports updated rates of response and disease ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the ...

Columnist Ben Hofmeister makes a presentation at this year's meeting of the Consortium of Multiple Sclerosis Centers on MS quality of care.

In 2026, accurate used car valuation is crucial due to evolving tax structures and supply chains. Utilising real-time data ...

The bispecific antibody linvoseltamab exhibited rapid clinical activity among patients with relapsed or refractory systemic light chain amyloidosis, according to phase 1/phase 2 trial results ...

Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50, ...

The new integration will “[provide] access to Walmart’s first-party data through a Walmart-controlled data enablement ...

The question that defines competitive position for business leaders is not primarily about infrastructure. It is about ...

Data centers driving AI growth spark backlash across NJ, with towns moving to ban projects over concerns about energy use, ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from ...

The primary objective of this study is to calculate the economic cost of excluding young Persons with Disabilities from the ...